Exam 2 Oncologic Emergencies Flashcards

1
Q

associated malignancies with TLS

A
  • Highest risk: Burkitt’s lymphoma, Lymphoblastic lymphoma, Acute leukemias
  • Moderate risk: Low-grade lymphomas, Multiple myeloma, Breast cancer, Small cell lung cancer, Germ cell tumors
  • Low risk: Medulloblastoma, Adenocarincomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

presenting lab values associated with TLS

A
  • hyperkalemia
  • hyperphosphatemia
  • hypocalcemia
  • hyperuricemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical presentation of TLS

A
  • hyperkalemia: Muscle cramps, weakness, N/V/D EKG changes, cardiac arrhythmias/arrest
  • hyperphosphatemia: Muscle cramps, tetany, seizures, arrhythmias, renal failure
  • hypocalcemia: Muscle cramps, tetany, mental status changes (confusion, hallucinations, seizures)
  • hyperuricemia: Acute renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

prevention of TLS

A
  • aggressive hydration before chemotherapy
  • 2000-3000 ml/m2/day x 24-48 hrs prior to therapy
  • remove external sources of K and Ph
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

allopurinol

A
  • max dose: 600-800 mg/day
  • prevent hyperuricemia, does not treat it
  • levels may not fall for 48-72 hours
  • renally adjust
  • ADE: rash, urticaria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rasburicase (Elitek®)

A
  • treatment and prevention of hyperuricemia
  • takes 4 hours to normal levels
  • take blood samples to see efficacy; blood samples must be on ice
  • caution use in pts w/ glucose-6-phosphatase deficiency
  • ADE: rash, mild N/V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

treatment for hyperkalemia

A
  • Calcium gluconate – stabilize cardiac cells
  • Cation exchange resins (sodium polystyrene sulfate;Kayexalate®) – exchange Na+/K+
  • NaHCO3, Dextrose 50% + insulin – shift K+ intracellularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment for hyperphosphatemia

A
  • Phosphate binders:
  • calcium acetate
  • PhosLo
  • sevelamer
  • Renagel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

associated malignancies with hypercalcemia

A
  • Lung cancer (35%)
  • Breast cancer (25%)
  • Multiple myeloma (7%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In a normal body, high calcium stimulates the body to release calcitonin to do what?

A

to decreases kidney Ca reabsorption which results in lower Ca levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normal Ca level

A

8.5-10.5 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

equation for corrected Ca

A

Corrected Calcium (mg/dL) = measured calcium + (0.8 x [4-albumin])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should you use the corrected Ca equation?

A

for patients with albumin < 4 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clinical presentation of hypercalcemia

A
  • Polyuria
  • Constipation
  • Nausea
  • Vomiting
  • Stupor
  • Seizures
  • Coma
  • Shortened QT interval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Classification of Hypercalcemia according to corrected calcium

A
  • Mild: <12
  • Moderate: 12-13.9
  • Severe: >=14
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

principles of treatment of hypercalcemia

A
  • Rehydration
  • Stop bone resorption
  • Treat the underlying cause
  • Remove external sources of calcium (food, meds)
17
Q

strategies used against hypercalcemia

A
  • Hydration
  • Diuretics
  • Bisphosphonates
  • Calcitonin
18
Q

symptomatic mild hypercalcemia

A
  • 1-2 liters over 2hr
  • Loop
  • possible IV bisphosphonates
19
Q

bisphosphonates

A
  • takes 4-10 days to work
  • last for 4-6 weeks
  • ADE: Nephrotoxic, Osteonecrosis of the Jaw, hypocalcemia, arhtralgia, infusion site reactions, fever
20
Q

moerdate hypercalcemia

A
  • 1-2 liters over 2hr
  • Loop
  • IV bisphosphonates
  • possible calcitonin
21
Q

calcitonin

A
  • Rapid decline in serum calcium within 4-6 hrs
  • possible tachyphylaxis
  • ADE: N/V, facial flushing, injection site pain
22
Q

severe hypercalcemia

A
  • 1-2 liters over 2hr
  • Loop
  • IV bisphosphonates
  • calcitonin
23
Q

associated malignancies with spinal cord compression

A
  • breast
  • lung
  • prostate
  • lymphoma
  • myeloma
24
Q

clinical presentation of spinal cord compression

A
  • pain
  • weakness
  • ataxia
  • sensory loss
25
Q

treatment for spinal cord compression

A
  • steroids

- analgeics